NCT06252168

Brief Summary

The Registry of Acute Myocardial Infarction (RAMI) aims at regular and centralized acquiring and processing standard information about verified and suspected cases of acute myocardial infarction (AMI), monitoring of AMI cases, and establishing AMI diagnosis based on standard diagnostic criteria by doctors involved in the registry. The RAMI obtains data from all medical institutions, which could potentially document any cases of suspected AMI.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97,500

participants targeted

Target at P75+ for all trials

Timeline
300mo left

Started Jan 1984

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Jan 1984Dec 2050

Study Start

First participant enrolled

January 1, 1984

Completed
40.1 years until next milestone

First Submitted

Initial submission to the registry

February 1, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 9, 2024

Completed
25.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2049

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2050

Last Updated

April 9, 2025

Status Verified

April 1, 2025

Enrollment Period

66 years

First QC Date

February 1, 2024

Last Update Submit

April 7, 2025

Conditions

Keywords

Acute Myocardial InfarctionAcute Coronary Syndrome

Outcome Measures

Primary Outcomes (1)

  • Early AMI lethality rate (%)

    Early acute myocardial infarction (AMI) lethality rate is calculated as percentage (%) of fatal outcomes that occurred within 28 days since onset of disease among subjects with verified or suspected AMI.

    28 days

Secondary Outcomes (1)

  • 12-month AMI lethality rate (%)

    12 months

Eligibility Criteria

Age20 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study population icnludes all subjects with verified and suspected acute myocardial infarction (AMI) in the city of Tomsk (Russian Federation) regardless of disease treatment, outcome, and healthcare institution esablishing diagnosis.

You may qualify if:

  • age of at least 20 years;
  • being a resident or visitor of the city of Tomsk at a time of AMI onset;
  • the presence of definite AMI or possible AMI. Definite AMI is diagnosed in the presence of characteristic ECG changes, regardless of clinical course and changes in serum enzymes; or the presence of typical pain syndrome, "ambiguous" ECG changes, and definite increase in the activity of serum enzymes i.e. exceeding the upper limit of normal by 25% or more; or macroscopically detected focus of myocardial necrosis and (or) fresh thrombotic occlusion of the coronary artery. Possible AMI is registered in the presence of typical pain syndrome with ambiguous ECG changes and an ambiguous (up to 25%) increase in the levels of serum enzymes; or the presence of obstruction in the lumen of at least one coronary artery by at least 50% and (or) the presence of a post-infarction scar in the myocardium with a diameter of 0.5 cm or more, while simultaneously excluding a non-coronary cause of death. In case of atypical clinical picture, ambiguous or absent ECG changes, when the enzyme levels are not determined or their activity does not reach a pathological level, AMI case is considered unconfirmed. In the absence of data that could confirm or not confirm AMI, the case is interpreted as "insufficient data"

You may not qualify if:

  • none.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tomsk National Research Medical Center, Russian Academy of Sciences

Tomsk, Russia

RECRUITING

MeSH Terms

Conditions

Myocardial InfarctionAcute Coronary Syndrome

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Alexei N. Repin, MD, PhD

    Tomsk NRMC

    STUDY DIRECTOR
  • Sergey A. Okrugin, MD, PhD

    Tomsk NRMC

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sergey A. Okrugin, MD, PhD

CONTACT

Nina D. Anfinogenova, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2024

First Posted

February 9, 2024

Study Start

January 1, 1984

Primary Completion (Estimated)

December 31, 2049

Study Completion (Estimated)

December 31, 2050

Last Updated

April 9, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations